Noor Al Obaidi, MBChB

Publications

• Al-Obaidi N, Mohan S, Liang S, Zhao Z, Nayak BK, Li B, Sriramarao P, Habib SL. Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes. FASEB J. 2019 Jan;33(1):373-387 
• Nehad M. Hamoudi, Noor Y. Al- Obaidi, Farman M. Khan, Drug Interaction Awareness among Public Attending GMCH Ajman/UAE. Asian Journal of Biomedical & Pharmaceutical Sciences. 
• Habib SL, Al-Obaidi NY, Nowacki M, Pietkun K, Zegarska B, Kloskowski T, Zegarski W, Drewa T, Medina EA, Zhao Z and Liang S. Is mTOR inhibitor good enough for treatment all tumors in TSC patients? J Cancer, Vol.7 
• Barbara Zegarska, Maciej Nowacki, Katarzyna Pietkun, Wojciech Jozwicki, Tomasz Nowikiewicz, Noor Y. Al-Obaidi, Samy L. Habib, Wojciech Zegarski, Adv Dermatol Allergol 2017; XXXIV (4): 375–380 
• Noor Al-Obaidi, Sumathy Mohan, Sitai Liang, Zhenze Zhao, Bijaya K. Nayak, Boajie Li, P. Sriramarao, and Samy L. Habib, Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes. FASEB J. 2019 Jan;33(1):373-387, doi: 10.1096/fj.201800555RR. Epub 2018 Jul 5.